Regencell Bioscience
5 hedge funds and large institutions have $281K invested in Regencell Bioscience in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
$217K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$30K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
$22.3K |
| 4 |
BlackRock
New York
|
$11.6K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
Morgan Stanley
New York
|
$159 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $217K | +$217K | +259,008 | New |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $30K | +$30K | +36,024 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $22.3K | +$22.3K | +26,524 | New |
|
|
4
BlackRock
New York
| $11.6K | +$3.99K | +4,750 | +53% |
|
|
5
Morgan Stanley
New York
| $159 | -$66.6K | -79,610 | -100% |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$144K | -1,110,284 | Closed |
|